Suppliers / Laboratoires Besins International

Laboratoires Besins International

France Updated 9 July 2026

Laboratoires Besins International is a finished-dose manufacturer based in France. It appears in 93 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, AIFA (IT) and INFARMED (PT). Its GMP standing is certified by ANSM (FR), EMA and NAFDAC (NG), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 20 April 2022 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
93
filings across 11 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 20 April 2022 VAI US FDA
  • 13 March 2019 VAI US FDA
  • 12 March 2015 VAI US FDA
  • 8 March 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Montrouge, France Not on file
France, France 3002844244
Paris, France Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 40 4
AIFA (IT) 22 None
INFARMED (PT) 10 None
MPA (SE) 7 None
NPRA (MY) 3 None
SFDA (Saudi Arabia) 3 None
ANSM (FR) None 18
NAFDAC (NG) None 1
EAEU_EEC None 1

Scale

Year Revenue Exports Destinations
2024 $31.5M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Laboratoires Besins International comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 20 April 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported